End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3222 USD | -2.36% | +2.32% | -20.05% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 9.98 | 129.4 | 177.5 | 22.43 | 23.62 | 16.1 | - | - |
Enterprise Value (EV) 1 | 9.98 | 129.4 | 177.5 | 22.43 | 23.62 | 16.1 | 16.1 | 16.1 |
P/E ratio | -0.06 x | -1.23 x | -1.38 x | -0.12 x | -0.06 x | -0.18 x | -0.15 x | -0.42 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | 3.04 x | 0.93 x | 0.84 x | 0.63 x |
EV / Revenue | - | - | - | - | 3.04 x | 0.93 x | 0.84 x | 0.63 x |
EV / EBITDA | - | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 42.7 | 958 | 2,481 | 9,206 | 58,615 | 95,544 | - | - |
Reference price 2 | 234.0 | 135.0 | 71.54 | 2.436 | 0.4030 | 0.1685 | 0.1685 | 0.1685 |
Announcement Date | 3/24/20 | 3/15/21 | 3/14/22 | 3/13/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | 7.768 | 17.3 | 19.2 | 25.68 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -28.83 | -50.51 | -92.31 | -112.1 | -118.4 | -76.79 | -66.85 | -46.81 |
Operating Margin | - | - | - | - | -1,523.94% | -443.87% | -348.18% | -182.27% |
Earnings before Tax (EBT) 1 | -28.62 | -50.46 | -92.29 | -110.2 | -116.7 | -80.7 | -76.4 | - |
Net income 1 | -31.09 | -52.17 | -92.29 | -116.9 | -116.7 | -75.19 | -65.25 | -45.61 |
Net margin | - | - | - | - | -1,501.78% | -434.62% | -339.84% | -177.59% |
EPS 2 | -3,866 | -110.0 | -52.00 | -20.44 | -6.850 | -0.9550 | -1.093 | -0.4000 |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/24/20 | 3/15/21 | 3/14/22 | 3/13/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | 3.989 | 3.779 | 3.95 | 3.95 | 4.5 | 4.55 | 4.2 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT | -18.54 | -29.56 | -26.44 | -23.34 | -29.59 | -32.73 | -33.9 | -29 | -28.15 | -27.33 | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | -705.62% | -723.18% | - | - | - | - | - |
Earnings before Tax (EBT) | -18.53 | -29.55 | -26.42 | -23.14 | -28.98 | -31.68 | -33 | -28.36 | -27.98 | -27.32 | - | - | - | - | - |
Net income | -18.53 | -29.55 | -26.42 | -27.4 | -28.98 | -34.08 | -33 | -28.36 | -27.98 | -27.32 | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | -701.3% | -723% | - | - | - | - | - |
EPS 2 | -10.00 | -14.00 | -10.00 | -7.625 | -4.312 | -3.500 | -3.250 | -2.680 | -1.830 | -1.820 | -0.3550 | -0.2250 | -0.2050 | -0.2050 | -0.2000 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/8/21 | 3/14/22 | 5/9/22 | 8/8/22 | 11/7/22 | 3/13/23 | 5/8/23 | 8/10/23 | 11/9/23 | 4/1/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 3/24/20 | 3/15/21 | 3/14/22 | 3/13/23 | 4/1/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- TNXP Stock
- TNXP Stock
- Financials Tonix Pharmaceuticals